Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$572M |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$495M |
| 3 |
iShares MBS ETF
MBB
|
+$405M |
| 4 |
Procter & Gamble
PG
|
+$365M |
| 5 |
Microsoft
MSFT
|
+$327M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Invesco QQQ Trust
QQQ
|
+$605M |
| 2 |
iShares Russell 2000 ETF
IWM
|
+$544M |
| 3 |
Sempra
SRE
|
+$474M |
| 4 |
CELG
Celgene Corp
CELG
|
+$411M |
| 5 |
BPL
Buckeye Partners, L.P.
BPL
|
+$380M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 8.85% |
| 2 | Healthcare | 5.77% |
| 3 | Financials | 5.26% |
| 4 | Consumer Discretionary | 4.71% |
| 5 | Communication Services | 4.69% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3726
PUT
Live Nation Entertainment
LYV
$42.5B
| $893K | ﹤0.01% |
12,500
+11,200
| +862% | +$759K |
|
|
AD
3727
Array Digital Infrastructure
AD
$3.1B
| $892K | ﹤0.01% |
24,616
-82,093
| -77% | -$2.88M |
|
3728
Gildan
GIL
$10.8B
| $891K | ﹤0.01% |
30,125
-128,566
| -81% | -$3.76M |
|
|
NOAH
3729
Noah Holdings
NOAH
$589M
| $891K | ﹤0.01% |
25,197
-49,477
| -66% | -$1.51M |
|
|
TUP
3730
DELISTED
Tupperware Brands Corporation
TUP
| $891K | ﹤0.01% |
103,693
+36,260
| +54% | +$395K |
|
|
SILK
3731
DELISTED
Silk Road Medical, Inc. Common Stock
SILK
| $888K | ﹤0.01% |
21,991
+16,124
| +275% | +$565K |
|
3732
Myers Industries
MYE
$1.33B
| $887K | ﹤0.01% |
53,155
+18,104
| +52% | +$301K |
|
3733
Equity Bancshares
EQBK
$1.06B
| $885K | ﹤0.01% |
28,653
+7,557
| +36% | +$216K |
|
3734
World Acceptance Corp
WRLD
$896M
| $885K | ﹤0.01% |
10,241
+3,110
| +44% | +$320K |
|
3735
LeMaitre Vascular
LMAT
$1.84B
| $884K | ﹤0.01% |
24,606
+5,953
| +32% | +$205K |
|
3736
First Community Bankshares
FCBC
$919M
| $883K | ﹤0.01% |
28,451
+13,560
| +91% | +$427K |
|
|
CHL
3737
PUT
DELISTED
China Mobile Limited
CHL
| $883K | ﹤0.01% |
20,900
+8,200
| +65% | +$331K |
|
3738
Toyota
TM
$223B
| $880K | ﹤0.01% |
6,263
+3,737
| +148% | +$522K |
|
3739
PUT
First Trust Natural Gas ETF
FCG
$622M
| $879K | ﹤0.01% |
72,900
-16,500
| -18% | -$179K |
|
|
YMAB
3740
DELISTED
Y-mAbs Therapeutics
YMAB
| $878K | ﹤0.01% |
28,062
+15,361
| +121% | +$454K |
|
3741
Center Bancorp
CNOB
$1.8B
| $877K | ﹤0.01% |
34,098
+17,749
| +109% | +$432K |
|
3742
PUT
Medifast
MED
$135M
| $877K | ﹤0.01% |
8,000
-10,800
| -57% | -$1.05M |
|
|
CCF
3743
DELISTED
Chase Corporation
CCF
| $876K | ﹤0.01% |
7,395
+3,521
| +91% | +$409K |
|
|
AGR
3744
DELISTED
Avangrid, Inc.
AGR
| $875K | ﹤0.01% |
17,105
-31,792
| -65% | -$1.58M |
|
3745
Kulicke & Soffa
KLIC
$4.88B
| $874K | ﹤0.01% |
32,117
-28,416
| -47% | -$701K |
|
3746
PagSeguro Digital
PAGS
$2.58B
| $873K | ﹤0.01% |
25,543
-56,051
| -69% | -$2.02M |
|
|
THR
3747
DELISTED
Thermon Group Holdings
THR
| $873K | ﹤0.01% |
32,605
-14,162
| -30% | -$357K |
|
3748
NextCure
NXTC
$21.1M
| $872K | ﹤0.01% |
1,290
+1,136
| +738% | +$570K |
|
3749
Red Robin
RRGB
$152M
| $872K | ﹤0.01% |
26,436
-5,636
| -18% | -$166K |
|
3750
CALL
Suncor Energy
SU
$72.7B
| $872K | ﹤0.01% |
26,600
-79,300
| -75% | -$2.48M |
|
Similar funds
Barclays's Q4 2019 Portfolio in Review
As of Q4 2019, Barclays held 7,254 positions worth $180B, up 13% from $160B the previous quarter. Its ten largest holdings account for 26% of the portfolio.
Barclays deployed $6.1B of net new capital in Q4 2019, opening 260 new positions and adding to 3,541 existing holdings. Its largest new stake was Pacer iPath Gold ETNs: 1,000,000 shares worth $25.3M.
By sector, the portfolio is most concentrated in Technology at 8.9% of assets, up from 7.7% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was Invesco QQQ Trust, an estimated $605M trimmed.
- Barclays's largest Q4 2019 buy was Pacer iPath Gold ETNs: 1,000,000 shares worth $25.3M.
- Barclays added most to Apple in Q4 2019, an estimated $572M increase.
- Barclays's biggest Q4 2019 reduction was Invesco QQQ Trust, cutting an estimated $605M.
- Barclays fully exited Celgene Corp in Q4 2019, selling an estimated $411M.
- Barclays's ten largest holdings make up 26% of its $180B portfolio in Q4 2019.
- Barclays opened 260 new positions and closed 700 in Q4 2019.
- Barclays's portfolio value rose 13% quarter-over-quarter to $180B.
Based on Barclays's 13F filing for Q4 2019, filed 10 Feb 2020.